Delivery Order SPE2DB24D2106-SPE2DB25FAVZW
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,410 firm fixed-price delivery order by the Defense Logistics Agency on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract calls for the delivery of TYPHIM VI 25 MCG/0.5 ML syringes—a typhoid conjugate vaccine used for immunization purposes—to support Department of Defense healthcare requirements. This delivery order was issued without...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,482.00 for Typhoid VI Polysaccharide vaccine. The contract, issued by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $22.23K by the Defense Logistics Agency on August 12, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a single shipment under the company's larger Indefinite Delivery Contract with DLA valued at $499.99M and valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $28,024.56 firm fixed-price delivery order by the Defense Logistics Agency for TYPHIM VI 25 MCG/0.5 ML syringes. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed in Conshohocken, Pennsylvania. This delivery order was issued without a set-aside designation and represents a single-product...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,410.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,781.69 for Typhoid VI Polysaccharide vaccine by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract, issued on August 18, 2025, with an ultimate completion date of August 28, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued against DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $55,633.80 for Typhoid VI Polysaccharide vaccine supplies. This firm fixed-price delivery order, issued on August 6, 2025, with an ultimate completion date of August 18, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a task order issued under DMS Pharmaceutical Group's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,490.61 for Typhoid VI Polysaccharide vaccine on August 11, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, which carries a potential value of $499,999,999 through November 2026. The award carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $6,490.61 for Typhoid VI Polysaccharide vaccine, with an ultimate completion date of September 8, 2025. This delivery order was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,544.60 for Typhoid VI Polysaccharide vaccine on July 23, 2025, with an ultimate completion date of August 4, 2025. This delivery order was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award represents a continuation of...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAVZWDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,174.25 by the Defense Logistics Agency on August 13, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a single shipment of this typhoid vaccine product to support military health facility requirements. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a full and open basis leveraging its established capabilities as a federal pharmaceutical supplier. This delivery order is issued under DMS Pharmaceutical Group's existing $499.999 billion Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which remains valid through November 2026. The IDC serves as the overarching vehicle enabling DLA to procure a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group's role as a prime contractor on this umbrella agreement demonstrates its critical position within the federal pharmaceutical supply chain, with the company maintaining a robust portfolio of delivery orders for vaccines, injections, prescription medications, and specialty pharmaceutical products across military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/13/25 |